S.Amdt. 3379

SA 3379. Ms. BALDWIN (for herself, Mr. Markey, and Mr. Menendez)
submitted an amendment intended to be proposed by her to the bill S.
524, to authorize the Attorney General to award grants to address the
national epidemics of prescription opioid abuse and heroin use; which
was ordered to lie on the table; as follows:

At the appropriate place, insert the following:

SEC. __. FUNDING FOR OPIOID AND HEROIN ABUSE PREVENTION AND
TREATMENT.

(a) Short Title.--This section may be cited as the ``Opioid
and Heroin Abuse Crisis Investment Act''.
(b) Funding.--There are authorized to be appropriated, and
are appropriated, out of monies in the Treasury not otherwise
obligated, $1,164,600,000 for the period of fiscal years 2017
and 2018, to improve opioid prescribing practices to reduce
opioid use disorders and overdose, to be made available in
accordance with this section.
(c) State Targeted Response Cooperative Agreements.--
Subpart 1 of part B of title V of the Public Health Service
Act (42 U.S.C. 290bb et seq.) is amended by inserting after
section 509 the following:

``SEC. 510. STATE TARGETED RESPONSE COOPERATIVE AGREEMENTS.

``(a) In General.--The Secretary shall enter into
additional targeted response cooperative agreements with
States under this title to expand opioid treatment capacity
and make services more affordable to those who cannot afford
such services.
``(b) Awarding of Funding.--The Secretary shall allocate
funding to States under this section based on--
``(1) the severity of the opioid epidemic in the State; and
``(2) the strength of the strategy of the State to respond
to such epidemic.
``(c) Use of Funds.--Amounts received by a State under this
section shall be used to expand treatment capacity and make
services more affordable to those who cannot afford such
services and to help individuals seek treatment, successfully
complete treatment, and sustain recovery.
``(d) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this section,
$460,000,000 for each of fiscal years 2017 and 2018.''.
(d) Treatment for Prescription Drug Abuse and Heroin Use.--
Section 331(b) of the Public Health Service Act (42 U.S.C.
254d(b)) is amended by adding at the end the following:
``(3)(A) The Secretary shall use amounts made available
under subparagraph (B) to

[[Page S1164]]

support enhanced loan repayment awards to increase the number
of clinicians in the Corps with medication assisted treatment
training to treat individuals with opioid use disorders
through loan repayments to clinicians.
``(B) From amounts appropriated under subsection (b) of the
Opioid and Heroin Abuse Crisis Investment Act, there shall be
made available to carry out this paragraph, $25,000,000 for
each of fiscal years 2017 and 2018.''.
(e) Evaluation of Medication-assisted Treatment.--Subpart 1
of part B of title V of the Public Health Service Act (42
U.S.C. 290bb et seq.) is amended by inserting after section
510, as added by subsection (c)) the following:

``SEC. 511. EVALUATION OF MEDICATION-ASSISTED TREATMENT.

``(a) In General.--In order to assess the treatment
outcomes of patients with opioid addiction receiving
medication-assisted treatment, the Secretary shall evaluate
the short, medium, and long-term outcomes of such substance
abuse treatment programs in order to increase effectiveness
in reducing opioid use disorders, overdose, and death.
``(b) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this section,
$15,000,000 for each of fiscal years 2017 and 2018.''.
(f) Medication-assisted Treatment for Prescription Drug and
Opioid Addiction.--Section 509 of the Public Health Service
Act (42 U.S.C. 290bb-2) is amended--
(1) by redesignating subsection (f) as subsection (g); and
(2) by inserting after subsection (e), the following:
``(f) Medication-assisted Treatment for Prescription Drug
and Opioid Addiction.--
``(1) In general.--In carrying out this section, the
Secretary shall use amounts made available under paragraph
(3) to award grants to States to expand or enhance medication
assisted treatment utilizing medications approved by the Food
and Drug Administration in combination with psychosocial
services, recovery support services, and coordination with
HIV or hepatitis C direct services.
``(2) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$50,100,000 for fiscal year 2017.''.
(g) Buprenorphine-prescribing Authority Demonstration.--
(1) In general.--To increase the availability of
medication-assisted treatment services for prescription drug
and opioid addiction, the Secretary of Health and Human
Services shall use amounts made available under paragraph (3)
to establish a demonstration project to test the safety and
effectiveness of allowing the prescribing of buprenorphine by
non-physician advance practice providers in accordance with
the providers' prescribing authority under applicable State
law.
(2) Targeting.--In carrying out the demonstration project
under paragraph (1), the Secretary of Health and Human
Services shall target populations and geographic areas that
are most affected by both high-need and limited access to
physicians authorized to prescribe buprenorphine.
(3) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$10,000,000 for fiscal year 2017.
(4) Demonstration project.--
(A) In general.--Notwithstanding subparagraph (B)(i) of
section 303(g)(2) of the Controlled Substances Act (21 U.S.C.
823(g)(2)(B)(i)), the Secretary of Health and Human Services
may, using amounts made available in this Act to carry out
title V of the Public Health Service Act, establish and carry
out a demonstration project through fiscal year 2021 in
which, for purposes of prescribing buprenorphine under such
section 303(g)(2), the term ``practitioner'' shall be deemed
to include non-physician providers authorized to prescribe
buprenorphine by the jurisdiction in which the provider is
licensed and who meet such criteria as determined appropriate
by the Secretary, in consultation with the Attorney General,
for participation in the project.
(B) Limitation.--In implementing the demonstration project
under subparagraph (A), the Secretary of Health and Human
Services and the Attorney General shall not be subject to the
requirements of section 553 of title 5, United States Code.
(C) Grants.--The Secretary of Health and Human Services may
enter into grants, contracts, or cooperative agreements with
one or more research institutions, and public and nonprofit
entities to assist in carrying out the demonstration project
under subparagraph (A). Amounts available for fiscal year
2016 to the Attorney General for carrying out such section
303 of the Controlled Substances Act shall also be available
to the Attorney General to facilitate and support the
efficient operation of the demonstration project under this
paragraph.
(D) Termination of authority.--Any authority provided under
this paragraph for a provider to prescribe buprenorphine
shall end not later than the date on which such provider
ceases to participate in the demonstration project under this
paragraph.
(h) Dissemination of Guidelines for Preventing Prescription
Drug Overdose.--Section 317 of the Public Health Service Act
(42 U.S.C. 247b) is amended by adding at the end the
following:
``(n) Dissemination of Guidelines for Preventing
Prescription Drug Overdose.--
``(1) In general.--The Director of the Centers for Disease
Control and Prevention shall disseminate guidelines to
improve opioid prescribing practices to reduce opioid use
disorders and overdose.
``(2) Use of funds.--In carrying out this subsection, the
Director of the Centers for Disease Control and Prevention
shall use amounts made available under paragraph (3) to--
``(A) pilot test, evaluate, and adapt comprehensive tools
and dissemination strategies to convey opioid prescribing
guidelines of the Centers for Disease Control and Prevention
in succinct, usable formats accessible to health care
providers;
``(B) develop, evaluate, and publicly disseminate clinical
decision support tools derived from the opioid prescribing
guidelines of the Centers for Disease Control and Prevention;
``(C) establish training modules in partnership with
professional societies and health systems, including online
modules available for continuing medical education credits
and maintenance of certification; and
``(D) coordinate with Office of the National Coordinator
for Health Information Technology to ensure that guidelines
developed under this subsection are effectively disseminated
and translated into clinical support tools for integration
into clinical workflow.
``(3) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$10,000,000 for fiscal year 2017.''.
(i) Rural Opioid Overdose Reversal Grant Program.--Section
330A of the Public Health Service Act (42 U.S.C. 254c) is
amended--
(1) by redesignating subsection (j) as subsection (k); and
(2) by inserting after subsection (i), the following:
``(j) Rural Opioid Overdose Reversal Grant Program.--
``(1) In general.--The Director may award grants to
eligible entities to implement activities for the prevention,
intervention, and treatment of opioid misuse and overdose.
``(2) Eligibility.--To be eligible to receive a grant under
this subsection, an entity--
``(A) shall be a rural public or rural nonprofit private
entity; and
``(B) shall represent a network composed of participants--
``(i) that include 3 or more health care providers; and
``(ii) that may be nonprofit or for-profit entities.
``(3) Use of funds.--Amounts awarded under a grant under
this subsection shall be used--
``(A) to provide opioid misuse education and prevention
services;
``(B) to provide training to licensed health care
professionals and first responders in the recognition of the
signs of opioid overdose and learn the appropriate way to
administer naloxone;
``(C) to provide appropriate transportation services to a
hospital or clinic for continued care after administration;
``(D) to refer those individuals with a drug dependency to
an appropriate substance use disorder treatment centers where
care coordination is provided by a team of providers; and
``(E) to purchase naloxone and opioid overdose reversal
devices.
``(4) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$10,000,000 for fiscal year 2017.''.
(j) Prescription Drug Overdose Initiative.--Section 3001(c)
of the Public Health Service Act (42 U.S.C. 300jj-11(c)) is
amended by adding at the end the following:
``(9) Prescription drug overdose initiative.--
``(A) In general.--The Secretary, acting through the
National Coordinator, shall use amounts made available under
subparagraph (B) to expand efforts to harmonize technical
standards to support prescription drug monitoring programs
and health information technology interoperability.
``(B) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$5,000,000 for fiscal year 2017.''.
(k) Bureau of Prisons Treatment Programs.--Section 4042 of
title 18, United States Code, is amended by adding at the end
the following:
``(e) Treatment Programs.--
``(1) In general.--The Director of the Bureau of Prisons
shall use amounts made available under paragraph (2) to
support drug treatment programs within the Bureau of Prisons,
including expanding the medication-assisted treatment pilot.
``(2) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$3,000,000 for fiscal year 2017.''.
(l) Second Chance Act of 2007.--Section 201 of the Second
Chance Act of 2007 (42 U.S.C. 17521) is amended--
(1) by redesignating subsection (f) as subsection (g); and

[[Page S1165]]

(2) by inserting after subsection (e), the following:
``(f) Community Reintegration.--
``(1) In general.--The Attorney General shall use amounts
made available under paragraph (2) to carry out activities to
reduce recidivism and increase public safety by helping
justice-involved individuals successfully reintegrate into
the community, including by carrying out activities including
providing treatment for co-occurring disorders and providing
family-based substance abuse treatment.
``(2) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this subsection,
$50,000,000 for fiscal year 2017.''.
(m) Residential Substance Abuse Treatment.--Section 503 of
the Controlled Substances Act (21 U.S.C. 873) is amended by
adding at the end the following:
``(e)(1) In carrying out this section, the Attorney General
may use amounts made available under paragraph (2) to provide
support for State, local, and tribal governments in the
development of residential and aftercare services for
substance-involved inmates.
``(2) From amounts appropriated under subsection (b) of the
Opioid and Heroin Abuse Crisis Investment Act, there shall be
made available to carry out this subsection, $14,000,000 for
fiscal year 2017.''.
(n) Heroin Enforcement Groups.--Part E of the Controlled
Substances Act (21 U.S.C. 871 et seq.) is amended by adding
at the end the following:

``SEC. 521. HEROIN ENFORCEMENT GROUPS.

``(a) In General.--The Attorney General shall use amounts
made available under subsection (b) to establish new heroin
enforcement groups with the Drug Enforcement Administration
to target, disrupt, and dismantle heroin trafficking
organizations.
``(b) Funding.--From amounts appropriated under subsection
(b) of the Opioid and Heroin Abuse Crisis Investment Act,
there shall be made available to carry out this section,
$12,500,000 for fiscal year 2017.''.
(o) Emergency Designations.--
(1) In general.--This section is designated as an emergency
requirement pursuant to section 4(g) of the Statutory Pay-As-
You-Go Act of 2010 (2 U.S.C. 933(g)).
(2) Designation in senate.--In the Senate, this section is
designated as an emergency requirement pursuant to section
403(a) of S. Con. Res. 13 (111th Congress), the concurrent
resolution on the budget for fiscal year 2010.
______